Clinical Trial Update: A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) [Phase 3]

View source ↗

Summary

Phase 3 IMpower111 trial comparing atezolizumab to gemcitabine plus cisplatin or carboplatin in PD-L1-selected stage IV squamous non-small cell lung cancer was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Cisplatin (Platinol) (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2018-11-14